日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Determination of in vitro immunotoxic potencies of a series of perfluoralkylsubstances (PFASs) in human Namalwa B lymphocyte and human Jurkat T lymphocyte cells

确定一系列全氟烷基物质 (PFAS) 对人类 Namalwa B 淋巴细胞和人类 Jurkat T 淋巴细胞的体外免疫毒性效力

Aafke W F Janssen, Wendy Jansen Holleboom, Deborah Rijkers, Jochem Louisse, Sjoerdtje A Hoekstra, Sanne Schild, Misha F Vrolijk, Ron L A P Hoogenboom, Karsten Beekmann

Inter- and Intraindividual Differences in the Capacity of the Human Intestinal Microbiome in Fecal Slurries to Metabolize Fructoselysine and Carboxymethyllysine

粪便中人类肠道微生物组代谢果糖赖氨酸和羧甲基赖氨酸的能力存在个体间和个体内差异

Katja C W van Dongen, Clara Belzer, Wouter Bakker, Ivonne M C M Rietjens, Karsten Beekmann

Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells

全氟烷基物质 (PFAS) 降低人类 B 淋巴瘤 Namalwa 细胞中重组激活基因 (RAG1 和 RAG2) 的表达

Aafke W F Janssen, Jochem Louisse, Deborah Rijkers, Nicole E T Pinckaers, Sjoerdtje A Hoekstra, Ron L A P Hoogenboom, Ad A C M Peijnenburg, Karsten Beekmann

Differences in gut microbial fructoselysine degradation activity between breast-fed and formula-fed infants

母乳喂养和配方奶喂养婴儿肠道微生物果糖赖氨酸降解活性的差异

Katja C W van Dongen, Athanasia Ioannou, Sebastiaan Wesseling, Karsten Beekmann, Clara Belzer

Interindividual Differences in Human Intestinal Microbial Conversion of (-)-Epicatechin to Bioactive Phenolic Compounds

人类肠道微生物将(-)-表儿茶素转化为生物活性酚类化合物的个体间差异

Chen Liu, Jacques Vervoort, Karsten Beekmann, Marta Baccaro, Lenny Kamelia, Sebas Wesseling, Ivonne M C M Rietjens

Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S-Equol and Its Consequences for ERα Activation

使用基于生理的动力学模型预测大鼠肠道微生物将大豆异黄酮代谢为 S-雌马酚及其对 ERα 激活的影响

Qianrui Wang, Bert Spenkelink, Rungnapa Boonpawa, Ivonne M C M Rietjens, Karsten Beekmann